Synthetic peptide conjugated to KLH, corresponding to C terminal amino acids 183-204 of Human MBD3L2 (NP_653215.2).
Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Immunogen affinity purified
Purified through a protein A column, followed by peptide affinity purification.
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/100 - 1/500. Predicted molecular weight: 23 kDa.
Detected at low levels in several somatic tissues. Highly expressed in the ovarian teratocarcinoma cell line PA1.
Belongs to the MBD3L family.
Information by UniProt
MBD3-like protein 2 antibody
Methyl-CpG-binding domain protein 3-like 2 antibody
This product has been referenced in:
et al. DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet 13:e1006658 (2017).
Read more (PubMed: 28273136) »
et al. BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skelet Muscle 7:16 (2017).
Read more (PubMed: 28870238) »
See all 2 Publications
for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"